PDCD1 and neoplasm: Studies have shown that the up-regulation of PD-L1 expression in tumor cells, especially when combined with PD-1 expressed by tumor infiltrating activated T cells, can induce exhaustion and inhibit the anti-tumor immune activity of these effector cells, thereby allowing tumor cells to escape from immunity (55).